Key Takeaways
|
Many people with type 2 diabetes or weight problems would prefer swallowing a tablet than injecting themselves. That is why oral semaglutide, sold as Rybelsus is popular these days. But a tablet is not simply a needle-free copy of the weight loss injection. It works differently in the body and comes with stricter rules.
This guide explains how semaglutide tablets work, how to take them, how they compare with the weekly injection and what to ask your doctor. It is for information only.
Not sure which treatment fits your diabetes or weight?
What Is Oral Semaglutide?
Semaglutide is a GLP-1 medicine. GLP-1 is a gut hormone that lowers appetite, slows stomach emptying and helps insulin work when blood sugar is high. Until recently, all GLP-1 medicines had to be injected, because proteins like these are broken down by stomach acid and enzymes.
Oral semaglutide solves this by combining the medicine with an absorption helper called SNAC. It lets the medicine pass through the stomach wall before it is destroyed (Buckley et al., 2018). Even so, only a small fraction of each tablet reaches the blood. That is why the tablet needs a higher dose and strict rules.
How to Take Rybelsus
The way you take Rybelsus affects how much medicine you absorb. Follow these steps exactly, unless your doctor tells you otherwise.
| Take it first thing in the morning on an empty stomach. ↓ Swallow one tablet whole with a small amount of plain water, up to about half a glass. Do not use tea, coffee, juice or other drinks. ↓ Do not split, crush or chew it. ↓ Wait at least 30 minutes before your first food, drink or other oral medicine. ↓ Take it every day. The usual plan starts at a low dose for 30 days and then steps up as your doctor advises. |
If you take the tablet with food or with a large drink of water, much less of the medicine is absorbed and it may not work as well. Check your product leaflet, and ask your pharmacist if anything is unclear. Rybelsus tablets are sold in India in 3 mg, 7 mg and 14 mg strengths for type 2 diabetes.
Semaglutide Tablets vs Injections
Semaglutide comes as both a daily tablet and a once-weekly injection. Both forms help manage blood sugar and can support weight loss but they differ in how you take them and how much weight you may lose.
The tablet needs to be taken on an empty stomach with a small amount of water, followed by a 30-minute wait before eating or drinking anything else. The injection is more convenient for people who prefer a weekly routine. Your doctor can help you choose the right form based on your health needs and treatment goals.
| Tablet (Rybelsus) | Injection (Ozempic or Wegovy) | |
| How it is taken | One tablet daily by mouth | One injection weekly under the skin |
| Rules | Empty stomach, small sip of water, 30-minute wait | No food rules, any time of day on the same day each week |
| Approved in India for | Type 2 diabetes | Ozempic for type 2 diabetes, Wegovy for weight management |
| Typical doses | 3, 7 or 14 mg daily | Ozempic 0.25 to 2 mg weekly, Wegovy up to 2.4 mg weekly |
| Weight loss | A few kilograms in diabetes trials | About 15 per cent of body weight with the 2.4 mg dose in adults with obesity (Wilding et al., 2021) |
| Heart safety evidence | Shown to be safe for the heart in PIONEER 6 (Husain et al., 2019) | Fewer heart attacks and strokes in SUSTAIN-6 (Marso et al., 2016) |
| Common side effects | Nausea, vomiting, diarrhoea, constipation, stomach pain | Nausea, vomiting, diarrhoea, constipation, stomach pain |
| Best for people who | Prefer no needles and can follow a strict morning routine | Prefer a weekly routine or need greater weight loss |
Which Works Better for Diabetes?
Both forms lower blood sugar. In the PIONEER trials, oral semaglutide lowered HbA1c more than placebo and was as good as or better than several other medicines for diabetes. In PIONEER 4, for example, oral semaglutide 14 mg lowered HbA1c by a similar amount to the injectable GLP-1 medicine liraglutide, and led to slightly more weight loss (Pratley et al., 2019).
We are not aware of a head-to-head trial of Rybelsus against Ozempic at licensed doses. The injection generally has a stronger effect on HbA1c and weight in separate trials, but these results cannot be compared directly, because the studies enrolled different people. Your doctor will also look at your HbA1c, kidney and heart health, other medicines, cost and daily routine.
| Clinical Insight “In my Ayurvedic practice, I also look at the patient’s eating habits, digestion and daily routine while assessing diabetes. These details help me plan dietary changes and Ayurvedic care alongside the patient’s prescribed treatment.” Dr. Gurudatta Amin, BAMS, MD, PGDEMS, 19+ Years of Clinical Experience, CMO, Madhavbaug |
Which Works Better for Weight?
For weight loss, the injection has the stronger and better-proven track record in India. The Wegovy injection at 2.4 mg led to an average loss of about 15 per cent of body weight over 68 weeks (Wilding et al., 2021). The standard Rybelsus doses used for diabetes lead to much smaller weight loss.
A higher oral dose has been studied for obesity. In the OASIS 1 trial, adults with obesity who took oral semaglutide 50 mg daily lost about 15 per cent of body weight over 68 weeks, compared with about 2 per cent on placebo (Knop et al., 2023). A 25 mg oral tablet for weight management has since been approved in several other countries. At the time of writing, we could not find an approval for it in India, so you should not expect to get it here. Ask your doctor and check the latest regulatory position before relying on any claim about an oral weight loss tablet.
Tablet or Injection – Easier To Adhere ?
A medicine only works if you take it correctly. If you know your mornings are rushed, or you often drink tea straight away, a weekly injection may suit you better. If you cannot face needles, the tablet may help you start.
| Consideration | Tablet | Injection |
| Fear of needles | No needles | A small pen needle, once a week |
| Routine | A strict daily morning routine, with a 30-minute wait before breakfast and tea | One fixed day each week |
| Missed doses | Easy to forget when mornings are rushed | Fewer doses to remember |
| Travel | Easy to carry | Needs correct storage and handling |
| Fasting, early or irregular meals | Harder to fit | Easier to fit |
Side Effects
The side effects are the same type for both, because the medicine is the same. Nausea, vomiting, diarrhoea, constipation and stomach pain are the most common, and they are usually worse when the dose is raised. Serious problems such as pancreatitis and gallbladder disease are less common but need urgent care.
Can You Switch Between the Tablet and the Injection?
Some people do switch. Not only they switch between Mounjaro and Ozempic but also between tablets and injections, for example because of needle fear, side effects or cost. The doses do not match one for one, so your doctor should set the new dose and timing. Please do not change on your own, and do not use the tablet and injection together.
“When a patient switches from a tablet to an injection or the other way around, I advise them to check the new dose and timing with their treating doctor first. I also review their diet and daily routine, as these can affect blood sugar control.” With this, appropriate monitoring with structured therapy leads to weight loss and reduced average blood sugar without any gastric issues.
– Dr. Bipin Gond, Zonal Medical Head, Madhavbaug
Weight Loss Care at Madhavbaug
If you are trying to lose weight while managing diabetes, it helps to look at both together. At Madhavbaug, doctors assess your weight, blood sugar, blood pressure and cholesterol before planning dietary changes, physical activity, sleep habits and Ayurvedic care suited to your health.
Tell your Madhavbaug doctor about any diabetes tablets, injections or other medicines you take. If your weight or blood sugar remains difficult to manage, visit your nearest Madhavbaug clinic to discuss your health and treatment options with a doctor.
For appointments or general enquiries, reach out to your nearest Madhavbaug clinic.
Want to know where you stand? Take Madhavbaug’s Diabetes Assessment Tool for a quick personal assessment, and discuss your result with your doctor.
Frequently Asked Questions
What are semaglutide tablets?
Semaglutide tablets are an oral form of semaglutide, a GLP-1 medicine. The tablet brand is Rybelsus, which is approved in India for type 2 diabetes. It is taken once a day on an empty stomach.
What is Rybelsus used for?
Rybelsus is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Is oral semaglutide the same as Ozempic?
The active medicine is the same, but the form, dose and rules differ. Ozempic is a weekly injection. Oral semaglutide is a daily tablet with a much higher dose, taken on an empty stomach.
Is a semaglutide tablet as good as the injection?
Both work. The injection usually produces a larger average effect on weight, and it does not need the strict morning routine. The tablet may suit people who cannot use needles. Your doctor can advise which fits you.
Can I use Rybelsus for weight loss?
Rybelsus is approved in India for type 2 diabetes, not for weight loss. Some people lose a few kilograms on it, but weight management needs medical advice.
How do I take Rybelsus?
Take one tablet in the morning on an empty stomach with a small sip of plain water, swallow it whole and wait at least 30 minutes before eating, drinking or taking other medicines.
What happens if I take the tablet with food?
Less medicine is absorbed and it may not work as well. Follow the leaflet instructions and ask your pharmacist if unsure.
References
Buckley, S.T., Baekdal, T.A., Vegge, A., et al. (2018) ‘Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist’, Science Translational Medicine, 10(467), eaar7047.
Husain, M., Birkenfeld, A.L., Donsmark, M., et al. (2019) ‘Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes’, New England Journal of Medicine, 381(9), pp. 841-851.
Knop, F.K., Aroda, V.R., do Vale, R.D., et al. (2023) ‘Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial’, The Lancet, 402(10403), pp. 705-719.
Marso, S.P., Bain, S.C., Consoli, A., et al. (2016) ‘Semaglutide and cardiovascular outcomes in patients with type 2 diabetes’, New England Journal of Medicine, 375(19), pp. 1834-1844.
Pratley, R., Amod, A., Hoff, S.T., et al. (2019) ‘Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial’, The Lancet, 394(10192), pp. 39-50.
Wilding, J.P.H., Batterham, R.L., Calanna, S., et al. (2021) ‘Once-weekly semaglutide in adults with overweight or obesity’, New England Journal of Medicine, 384(11), pp. 989-1002.








